Clinical Trial Update: Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intravesical instillation of botulinum toxin type A for urge urinary incontinence.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Glostrup University Hospital, Copenhagen | Conditions: Urge Urinary Incontinence | Phase 1, Phase 2 | Status: UNKNOWN